Blood immunoglobulins, complement and TNF receptor following minimally invasive surgery in patients undergoing pulmonary lobectomy by Leaver, H. Anne et al.
Strathprints Institutional Repository
Leaver, H. Anne and Craig, Stewart R. and Rotondo, Dino and Walker, 
William S. (2015) Blood immunoglobulins, complement and TNF receptor 
following minimally invasive surgery in patients undergoing pulmonary 
lobectomy. Current Metabolomics, 2 (3). pp. 196-203. ISSN 2213-2368 , 
http://dx.doi.org/10.2174/2213235X03666150106232345
This version is available at http://strathprints.strath.ac.uk/56353/
Strathprints is  designed  to  allow  users  to  access  the  research  output  of  the  University  of 
Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights 
for the papers on this site are retained by the individual authors and/or other copyright owners. 
Please check the manuscript for details of any other licences that may have been applied. You 
may  not  engage  in  further  distribution  of  the  material  for  any  profitmaking  activities  or  any 
commercial gain. You may freely distribute both the url (http://strathprints.strath.ac.uk/) and the 
content of this paper for research or private study, educational, or not-for-profit purposes without 
prior permission or charge. 
Any  correspondence  concerning  this  service  should  be  sent  to  Strathprints  administrator: 
strathprints@strath.ac.uk
 1 
Accepted manuscript 
 
 
Blood Immunoglobulins, Complement and TNF receptor following Minimally 
Invasive Surgery in Patients Undergoing Pulmonary Lobectomy  
 
 
H Anne Leavera, Stewart R Craigb, Dino Rotondoc, and William S Walkerd  
a Cell Biology R&D, SNBTS & Clinical Neurosciences Edinburgh University, b Department of 
Cardiothoracic Surgery, Golden Jubilee Hospital, Glasgow,   c Strathclyde Institute of Pharmacy & 
Biomedical Sciences, Strathclyde University, Glasgow, and d Division of Cardiothoracic Surgery, 
Royal Infirmary, Edinburgh  
 
 
Correspondence to: Dr HA Leaver, Cell Biology Laboratory, SNBTS,  (OOHQ¶V *OHQ 5RDG
Edinburgh EH177GT, UK.  
 
Telephone Number: (UK)-131-314-5680 Fax: (UK)-131-536-6764  
e-mail: hanne.leaver@gmail.com 
 
Running Title: 
Blood Immunoglobulins, Complement and TNF receptor following Minimally Invasive Surgery (10 
words) 
 
Keywords: Mediators, Minimally Invasive Pulmonary Lobectomy (5 words)  
 2 
Abstract 
 
The reasons for improved survival following minimally invasive surgery remain elusive. Circulating 
mediators link surgical trauma, vascular and tissue homeostasis. Acute phase reactants, leukocytes and 
leukocyte Reactive Oxygen Species (ROS) are affected differentially by minimally invasive video-
assisted thoracic surgery (VATS). Also, immunoglobulins, complement, TNF receptor and P-selectin 
changes have been observed, but the influence of minimally invasive surgery on these opsonins is less 
well defined. In this prospective randomised trial, 41 patients were randomly assigned to minimally 
invasive or open thoracic surgery, and immunoglobulins and vascular endothelial damage biomarkers 
were analysed. Humoral mediators (blood IgG, IgM, IgA; complement fragments C3, C4, and 
complement haemolytic index of activation CH50; TNF receptors I, II and P-selectin) were analysed 
before and 2, 5 and 7 days after surgery. Post-surgical changes in individual patients were determined.  
 
Substantial immunoglobulin decreases followed minimally invasive and open surgery. Decreased IgG, 
IgM and IgE were detected 2 days after surgery, and IgG and IgM after 7 days. These changes were 
greater than haemodilution, reaching greater significance in open surgery patients. Immunoglobulin 
decreases followed lymphocyte decreases. In contrast, increased complement and inflammatory 
endothelial cell signals (C3 and C4, soluble TNFR-II) were detected 7 days after surgery. In both 
groups, increased C3 and TNFR-II followed early acute phase reactants CRP, IL-6 and ROS. Acute 
phase reactants and CD4/CD8 lymphocytes were factors most attenuated in patients undergoing 
minimally invasive thoracic surgery (VATS). This study suggests local trauma mediators are better 
biomarkers than circulating opsonins in defining the response to minimally invasive surgery, and a 
systems approach, comparing individual metabolic responses, is effective in small patient groups. 
 
 
INTRODUCTION 
 
Major cardiothoracic surgery is associated with release of local and systemic mediators, acting on 
vascular and pulmonary systems which may be compromised by underlying disease [1]. Although 
improvements in survival and infection rates have been reported following minimally invasive surgery, 
the underlying mechanisms remain poorly defined. Following surgery, there have been reports of 
improved outcomes of minimally invasive techniques on immunosuppression, measured as infection 
rates, circulating lymphocytes and immunoglobulins [2-6]. Circulating immunoglobulins play an 
important part in immunity and immunoglobulin preparations have been used for prophylaxis for 
patients at high risk from sepsis [7, 8]. However, there has been little analysis of whether differences in 
post surgical immunoglobulins are due to changes in immunoglobulin turnover or blood loss. Also, 
prospective randomised trials of minimally invasive surgery have become more difficult to perform, as 
the use of conventional open surgery has decreased and minimally invasive approaches have become 
the method of choice. In the current randomised prospective study of minimally invasive pulmonary 
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lobectomy, humoral opsonins, including immunoglobulins, complement, selectins and TNF binding 
proteins were analysed, to determine immunological and humoral biomarkers following surgery. 
 
It is well known that the cytokine network is closely linked to inflammatory and vascular signals, and 
emerging evidence suggest that it undergoes specific changes following minimally invasive surgery. 
IL-6 is a characteristic marker of minimally invasive surgery. IL-6 levels increased by up to 18-fold 
within two days of major surgery [9]. We previously detected lower IL-6 release in VATS, compared 
with conventional open surgery in the patient group used in this study following pulmonary surgery 
[10]. Characteristic IL-6 changes were also detected in other sites of minimally invasive surgery. In a 
study of laparoscopic excisions for rectal cancer, IL-6 decreased 1 and 5 days after laparoscopic 
surgery, but increased after open surgery, but not TNF [11]. In the patient group covered by this study 
we also reported that TNF was unchanged, and in this paper we describe post surgical changes in 
circulating TNF binding proteins which may neutralise locally released TNF. We also report post 
surgical changes in opsonins that link humoral mediators including IL-6 and lung tissue immunity: 
selectins and complement. The selectins link stress signals, including NF-Ƹ%DQG$7)-2 factors, to 
vascular responses. P-, E-, and L-selectin recognize leukocyte and endothelial glycoproteins and P-
selectin is elevated in patients with haemolytic disease and lung cancer [12-14]. Complement and 
selectins also act as acute phase mediators [14]. Complement serum proteins, especially C3 and C4, 
may be produced by a wide variety of tissues and circulating immune cells such as macrophages, 
although the greatest amount originates from the liver [15].  C3 and C4, especially, are associated with 
elevated IL-6, which stimulates renal acute phase protein production [16]. Elevated haemolytic 
complement activity (CH50), a biomarker of haemolytic complement in the classical pathway, is 
associated with cancer, infection and conditions associated with chronic inflammation [15]. Therefore, 
in this study, the role of these circulating opsonins in linking immunological and vascular responses 
(CH50 and P-selectin) were investigated.  
 
The immunoglobulins are major humoral mediators, playing a central role in immune surveillance and 
also a local role in lung pathophysiology. This study investigates the impact of pulmonary surgery on 
circulating immunoglobulins. The lung is a site of specific anaphylactic responses and of 
immunosurveillance. In the patient group used in this study, we previously reported differential 
changes in immunoglobulin producing B cells and T cells controlling the immune response following 
minimally invasive surgery [3]. Additionally, oxygen tension in pulmonary tissue is high, and changes 
in oxidative metabolism were detected in circulating leukocytes, which differed in VATS patients [3, 
10]. However, while there have been recent advances in understanding ROS bioactivity at a cellular 
level, less is known about their activity in integrated whole body network responses. In the current  
study, changes in immunoglobulins, complement, selectins and TNF binding proteins were analysed in 
individual patients. These changes were compared with previously identified cellular and humoral 
biomarkers (ROS and acute phase mediators), to investigate potential network and mediator 
interactions during the post-operative period. 
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MATERIALS AND METHODS 
 
In this communication, we present previously unpublished data obtained from a prospective 
randomised trial, analysing peripheral venous blood samples collected during a study of acute phase 
[10] and leukocyte [3] changes following minimally invasive or conventional surgery for brochogenic 
carcinoma. The numbers of patients in each group was calculated from previous reports of leukocyte 
changes after surgery [3] derived from post surgical leucocyte ranges reported in laparoscopic surgery 
trials, and patient inclusion criteria have been described [3, 10]. To summarize, patients with peripheral 
pulmonary opacity consistent with peripheral brochogenic carcinoma underwent standard surgical 
assessment and staging by bronchoscopy, mediastinoscopy and computed axial tomography of thorax 
and upper abdomen. Routine haematological and biochemical analysis (Haemoglobin, urea) and blood 
loss analysis was performed to monitor haemodilution following surgery. Local ethical committee 
permission was obtained, and patients scheduled to undergo pulmonary lobectomy were randomly 
allocated to VATS or open surgery. There was no significant difference in age or histological diagnosis 
between the two study groups: Median age was 62 (47-74) in open surgery, compared with 64.5 (46-
78) in VATS patients; sex ratio 14/5 (open surgery) and 8/14 M/F (VATS). Clinical outcomes have 
been described in detail [10], µduration of surgery, length of stay and pathology in the two groups were 
not significantly different. Complications were: one patient with intrapleural adhesions, bleeding and 
lung collapse, and one patient with poor respiratory function in the VATS group; three cases of 
pulmonary infection, and one case of cardiac dysrythmia in the open group. 
 
The VATS technique involved 4-5 cm submammary incision over the postero-lateral chest wall. The 
open approach involved limited thoracotomy, avoiding trapezius and rhomboid muscles, but divided 
the latissimus dorsi and the posterior third of serratus anterior. Both techniques involved initial 
identification of the pulmonary artery and division of fused fissures, then dissection and division of 
hilar structures. Equivalent nodal dissection was carried out in open and VATS patients and anaesthetic 
and analgesic regimens did not differ between groups. Post-operative pain control was managed with 
patient-controlled morphine administration, supplemented by intercostal nerve blocks as required and 
oral analgesia. No non-steroidal anti-inflammatory drugs or blood transfusion (which is associated with 
immunosuppression) was used. Fasting venous blood samples were obtained pre-operatively and at 2 
and 7 days post-operatively from 41 patients allocated randomly to alternative study groups at the time 
of surgery. Inflammatory/ endothelial biomarkers were analysed in a smaller cohort of 23 patients as an 
additional preliminary study, with more frequent sampling in order to determine the time course of any 
post surgical changes. There was no selection or exclusion of data for any patients or markers and the 
individuals involved in analysis were unaware of the operative technique used.¶ 
 
Laser nephelometry was used to measure IgG, IgM, IgA, C3, C4 [17, 18]. Haemolytic activity of 
complement (CH50), used haemolysis of sheep erythrocytes sensitized by C3, C4 specific antibodies 
(One CH50 unit: volume of serum lysing 50% erythrocytes). P-selectin TNFR-I and -II were analysed 
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using monoclonal antibodies supplied by British Biotechnology, London UK and Monosan, Brussels, 
Belgium, respectively based ELISA, as described previously [10]. The change in opsonins and 
mediators after surgery was calculated as percent of pre-surgical levels within each patient. Results are 
expressed as median or mean + SEM. Results significantly different from pre-surgical levels were 
analysed using the Wilcoxon matched pairs signed two tailed rank test, comparing pre-operative and 
post-operative opsonin levels within the same patient. Significantly different results were dentoted * 
p<0.05, ** p<0.005 and *** p<0.0005. The correlation between changes in related parameters after 
surgery was analysed using simple linear regression analysis. Patients with malignant histology 
predominated in both open and VATS study groups. There were 18 patients with malignancy in the 
open surgery group and 18 patients with malignant histology in the VATS group. 
  
 
Table 1. Immunoglobulin depletion and Complement activation following Conventional or Minimally 
Invasive Surgery.  Median concentrations in plasma + SEM in IgG, IgM  and IgA in 19 patients 
undergoing Open Surgery and 22 Minimally Invasive Surgery (VATS) patients, before (day 0) and 
days 2 and 7 post-op. * results significantly p<0.05 different from paired pre-surgical (day 0) levels in 
same patient; *, p<0.05; **, p<0.005; ***, p<0.0005. ¥, and indicators of haemodilution (Haemoglobin 
Hb) and renal function (Urea) day 0, day 1 post-op, median + SEM. 
 
Open Surgery 
Days Post-Op 0 2 7 
IgG  
IgM 
IgA 
g L-1 x 100 
g L-1 x 10 
g L-1 x 10 
10.6 + 0.57 
1.1 + 0.14 
2.42 + 0.25 
8.36 + 0.52*** 
0.79 + 0.15*** 
2.04 + 0.28*** 
9.57 + 0.57** 
0.93 + 0.14** 
2.44 + 0.34 
C3 
C4 
CH50 
g L-1 
g L-1 
U 
1.19 + 0.07 
0.3 + 0.02 
84 + 34.4 
1.26 + 0.06 
0.34 + 0.02 
76 + 6.3* 
1.53 + 0.06** 
0.39 + 0.02** 
109 + 8.7 
Hb¥ 
Urea¥ 
g/dL 
mMol L-1 
14.0 + 0.5 
4.45 + 0.57 
13.0 + 0.6 
5.05 + 0.52 
 
Minimally Invasive Surgery 
Days Post-Op 0 2 7 
IgG  
IgM 
IgA 
g L-1 x 100 
g L-1 x 10 
g L-1 x 10 
9.89 + 0.61 
0.77 + 0.11 
2.36 + 0.35 
8.76 + 0.57*** 
0.63 + 0.10* 
2.29 + 0.33*** 
9.13 + 0.65** 
0.86 + 0.12 
2.33 + 0.38 
C3 
C4 
CH50 
g L-1 
g L-1 
U 
1.24 + 0.06 
0.33 + 0.02 
73 + 11.1 
1.22 + 0.04 
0.31 + 0.16 
68 + 10.1 
1.62 + 0.07*** 
0.43 + 0.02*** 
70 + 10.2 
Hb¥ 
Urea¥ 
(g/dL) 
mMol L-1 
13.5 + 0.5 
4.1 + 0.33 
12.5 + 0.6 
4.3 + 0.28 
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RESULTS 
 
Changes in Immunoglobulins following Surgery 
 
Substantial decreases in venous IgG, IgM and IgA were detected after surgery in patients undergoing 
pulmonary lobectomy (Table 1). In pre-operative patients, a relatively wide range of  immunoglobulin 
levels were detected, which overlapped with postoperative immunoglobulin levels (Fig 1) and therefore 
post-operative changes in individual patients were analysed, as these changes were the focus of this 
study. IgG, IgM, IgA decreases (+SEM) were: IgG 21+3%(18+2%), IgM 13+3%(6+10%),  IgA 
decreased by 18+4% (12+2%) in open and (VATS) patients 48 hours after surgery, and decreased 
13+3%(12+3%) IgG, was detected one week post-operatively (Fig 2A). IgM also significantly 
decreased one week postoperatively in open surgery patients, but not in VATS patients (Fig 2B). IgG, 
IgM and IgA were significantly different from pre-operative immunoglobulins, 2 days after surgery.  
Postoperative changes in IgM reached greater significance in open surgery patients.  
  
 
Fig 1. Immunoglobulin G after Conventional Open Surgery or Minimally Invasive Surgery. Venous 
IgG in patients undergoing (A) conventional Open surgery (B) Minimally invasive surgery (VATS). 
Samples were taken pre-operatively (0) and 2 and 7 days after surgery.  
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Fig 2. Post-operative Changes in plasma IgG, IgM and IgA after Conventional Open or Minimally 
Invasive Surgery. Open Surgery (dashed) Minimally invasive, VATS (solid lines). Results are median 
+ SEM percentage change within the same patient in (A) IgG, (B) IgM  and (C) IgA in 19 patients 
undergoing open surgery and 22 VATS patients.  Asterisks denote results significantly different from 
pre-operative immunoglobulins, *p<0.05; **p<0.005; ***, p<0.0005.  
 
 
Haemodilution was 9.9+3.1% in open surgery and 9.0+2.1% in minimally invasive Surgery (VATS), 
and median blood loss was 250ml (range 100ml-2.1L) in open surgery patients and 63ml (range 0-
220ml) in VATS patients. Thus haemodilution was lower than the 12% - 21% decrease in 
immunoglobulin concentration following surgery. Therefore, this study suggested that haemodilution 
only contributed partially (25-50%), to immunoglobulin depletion. Other effects of surgery may 
include effects on immunoglobulin production and consumption, and evidence for the former was 
obtained from lymphocyte analysis following surgery. 
 
Evidence for an effect of minimally invasive surgery on immunoglobulin production in the patient 
group used in this study included a substantial decrease in lymphocytes following surgery [3]. The 
kinetics of immunoglobulin (Fig 2) and lymphocyte decreases were similar: both circulating 
immunoglobulins and lymphocyte numbers decreased two days after surgery. Immunoglobulin 
decreases were more significant in patients undergoing open surgery (Table 1 and Fig 2). Decreases in 
immunoglobulin producing cells and T cells were previously reported in this patient group (B cell 
numbers decreased by 22% in open surgery, and 18% in VATS patients two days after surgery), and 
even greater decreases were observed in CD4 T helper cells (32% after open surgery, 22% in VATS) 
[3].  
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Complement and TNF Receptor Release following Surgery 
 
Pulmonary surgery was associated with increased complement release, detected as circulating C3 and 
C4 one week after surgery (Table 1, Fig 3A). C3 and C4 increased 29+9% 7 days after surgery 
(P<0.005, paired t-test, comparing pre- and post-surgical C3, C4 within same patient). There was 
evidence of reduced C4 release in VATS (31+11% open surgery; compared with 22+6% in VATS 
patients). The complement increase occurred later than immunoglobulin changes, which were 
significantly greater on day 2 after surgery (Fig 2), and there was evidence of reduced C4 release in 
VATS patients (Fig 3A). Increased post-operative C3 and C4 in VATS and open surgery could indicate 
DVORZRQVHW³DFXWH-SKDVH´UHVSRQVH7KLVUHVSRQVHPD\EHSDUWLDOO\LQIODPPDWRU\DVFRPSOHPHQW
haemolytic index of activation (CH50) indicated end-activation of complement at day 7 in open 
surgery, but not in VATS patients (Table 1).  Proteolytic cleavage of C3 or C4 during complement 
activation depletes serum C3 and C4.  The high correlation between C3 and C4 changes indicated a 
possible common clearance pathway in thoracotomy patients.    
 
Table 2. Inflammatory/Endothelial Biomarker increases after Conventional or Minimally Invasive 
Surgery. Results are median concentration, ng/ml, in plasma samples, analysed in 12 patients 
undergoing open surgery and 11 VATS patients, taken before (0 days post-op  and on days 2 and 7 
post-op. The number of patient samples analysed at each time point are shown in parenthesis * results 
significantly p<0.05 different from paired pre-surgical (day 0) levels in same patient; *, p<0.05; **, 
p<0.005; ***, p<0.0005.   
   
 Open  Surgery 
Hours 
Post-Op 
0 4 24 48 72 120 168 
TNFR-II 3.82+0.1 
(12) 
3.87+0.1 
(11) 
3.75+0.16 
(12)* 
4.3+0.14 
(11) ** 
3.65+0.21 
(8) 
5.21+0.25 
(6)  
4.72+0.14 
(11) * 
TNFR-I 0.82+0.1 
(12) 
0.69+0.11 
(11) 
0.89+0.13 
(12)* 
0.86+0.13 
(11) *** 
1.07+0.18 
(8)* 
1.21+0.17 
(6)* 
1.01+0.18 
(11) *** 
P-selectin 121+25.1 
(12) 
118+39.7 
(11) 
139+27.7 
(12) 
144+19.5 
(11) 
151+25 
(8) 
158+63.4 
(6) 
150+34.4 
(11) 
Minimally Invasive Surgery 
Hours 
Post-Op 
0 4 24 48 72 120 168 
TNFR-II 3.61+0.13 
(11) 
4.42+0.14 
(10) 
4.19+0.13 
(11) 
4.31+0.19 
(11) 
3.77+0.47 
(8) 
3.81+0.35 
(6) 
5.81+0.2 
(10) * 
TNFR-I 0.94+0.09 
(12) 
1.07+0.11 
(12) 
1.19+0.14 
(12) ** 
1.53+0.17 
(11) *** 
1.39+0.19 
(9) * 
1.17+0.17 
(6) 
1.74+0.14 
(12) ** 
P-selectin 83.6+42.7 
(12) 
74.0+37.7 
(12) 
40.4+20.6 
(12) * 
48.3+24.7 
(11)  
83.8+42.8 
(9) 
62.1+31.7 
(6) 
67.5+34.5 
(12) 
 
In this preliminary study of inflammatory and endothelial biomarker changes, we detected gradual 
increases 2-7 days after thoracotomy (Table 2). In this small study group, no significant early changes 
in these markers were detected in the immediate post surgical period, in samples taken 4h after surgery, 
but changes were detected at 2-7 days after surgery. Soluble human TNFR type I/II increased after 
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surgery and similar TNFR-I increases were detected in both surgical groups. However, increased 
TNFR-II (linked to immunomodulation) was detected in open thoracotomy (but not VATS) patients 
48h and 120h post-op (Fig 3B). Pre-operative TNFR-II levels in our study fell within the normal range, 
121+ 84 ng/ml. It was also observed that P-selectin decreased 24-48h post-op in VATS patients, 
whereas a gradual increase (of up to 60%), was detected in open surgery patients [12, 14].  
 
 
Fig 3. Post-operative Changes in plasma C4, and TNFR-II after Conventional and Minimally Invasive 
Surgery. Open Surgery (dashed) and minimally invasive surgery VATS (solid lines). Results show 
median + SEM percentage change in same patient in (A) C4 in 19 patients undergoing open surgery 
and 22 VATS patients. (B) TNFR-II in 12 patients undergoing open surgery and 11 VATS patients. 
Results significantly different from pre-operative values (day 0), *p<0.05; **p<0.005; ***, p<0.0005.  
 
DISCUSSION 
The period immediately following surgery is important for survival. Acute phase and local mediators of 
surgical trauma influence immunity, vascular and pulmonary function [10, 11]. These mediators are 
involved in the response to infection and longer term processes, including metastatic growth [19]. 
While minimally invasive surgery is associated with improved morbidity and mortality [2], the 
underlying mechanisms are complex and involve humoral and cellular networks of the immune and 
vascular sytem [20]. The aim of this study was to analyse post-surgical immunoglobulins, complement 
and other opsonins, to find whether minimally invasive surgery affected these mediators, and to relate 
these changes to other biomarkers of immune function and surgical trauma. Changes in opsonins and 
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inflammatory/endothelial biomarkers were analysed within individual patients in a randomised 
prospective study of 41 patients undergoing pulmonary lobectomy. Substantial changes in opsonins 
were detected after surgery, but differences between surgical groups were small, suggesting that 
minimally invasive surgery had less impact on opsonisation than on acute phase changes in these 
patients. 
 
Immunoglobulins play an important part in immunity. Venous IgG, IgM and IgA decreased 
substantially following surgery (Table 2). Both circulating immunoglobulin (Fig 2) and lymphocyte 
numbers [3] decreased two days after surgery, and immunoglobulin decreases were more significant in 
patients undergoing open surgery (Fig 2). These immunoglobulin decreases were greater than the 
haemodilution observed in these patients (Table 1), and immunoglobulin differences between surgical 
groups were also greater than haemodilution differences. We previously reported decreases in 
immunoglobulin producing B cells and T cells in the patient group used in this study and also 
differences between lymphocyte counts in open and minimally invasive patients [3]. A similar pattern 
of immunoglobulin and lymphocyte changes were detected following laporoscopic cholecytstectomy, 
with lymphocyte changes that were greater than blood immunoglobulin changes [21]. Also, we 
observed that lymphocyte ROS, which influence lymphocyte proliferation and apoptosis [22], were 
lower in VATS patients [3, 4, 20]  and see this edition of Current Metabolomics, Leaver et al (2015) 
Cellular and Humoral Responses following Minimally Invasive Surgery: Role of Reactive Oxygen 
Species, in which we propose that ROS may mediate many effects of surgical stress.  
 
As other indicators of surgical stress had previously been analysed in this patient group [3, 10], it was 
possible to compare these biomarkers with the opsonins analysed in the present study. Correlations 
between immunoglobulin and other biomarkers of open and minimally invasive surgery are shown in 
Fig 4. On the left side of each dendrogram, IgG changes are compared with indicators of haemodilution 
and T lymphocytes, on the right are highlighted changes in local signalling mediators (ROS), including 
lymphocyte ROS.  
 
Fig 4. Dendrograph indicating links between Humoral and Cellular Mediators following Conventional 
Open or Minimally Invasive Surgery.  The correlation between changes in related parameters after 
surgery was analysed using linear regression, and the length of individual branches denotes the 
correlation coefficient r for paired haematological, immunological and metabolic markers following 
surgery. This figure shows the correlation between post-surgical changes (dashed lines: negative, solid 
lines: positive) in 41 patients undergoing pulmonary lobectomy, comparing humoral, haematological 
and immunological factors in A) Open surgery, and B) VATS patients. Urea and blood loss (BL) 24h 
after surgery negatively correlated with Haemoglobin (Hb). Also, close correlations were observed 
between IgG and CD4 B lymphocytes in both surgical groups 2 days post surgery. In contrast, the 
correlation between Haemoglobin and IgG changes 2 days after open surgery was attenuated in VATS 
patients. Correlations between IgG and IgA changes indicated similar effects of VATS and open 
surgery, 2 days after surgery. On the right, negative correlations between lymphocyte 
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number/lymphocyte ROS were detected 2 days after open surgery, but a positive correlation was 
detected in VATS patients. Differences between VATS/open surgery were detected in monocyte 
(mROS) and neutrophil (nROS), compared with Complement (C3 and C4) 7 days after surgery.  
 
 
Changes in markers of haemodilution (urea and blood loss) after open surgery showed negative 
correlation with Haemoglobin, and this correlation was similar in VATS patients. Also, IgG and CD4 T 
lymphocyte changes showed close correlations in both surgical groups 2 days post surgery. In contrast, 
the correlation between haemodilution (Haemoglobin) and IgG changes observed 2 days after open 
surgery was much lower in VATS patients, indicating that the lower haemodilution in VATS patients 
had less impact on IgG levels after surgery. Correlations between IgG and IgA changes were similar 
after VATS and open surgery, indicating similar production/consumption in both patient groups 2 days 
after surgery.  
 
On the right of each dendrograph is shown a negative correlation between lymphocyte number and 
lymphocyte ROS 2 days after open surgery, but a positive correlation in VATS patients. This supports 
findings that suggest that higher ROS levels are cytotoxic in lymphocytes. Differences between 
minimally invasive and open surgery in monocyte and neutrophil ROS were observed, compared with 
Complement (C3 and C4) 7 days after surgery. Less negative correlations between C3 and C4 and 
phagocyte ROS were detected in VATS patients indicating higher connectivity between opsonins and 
immune signalling after minimally invasive surgery. Pulmonary surgery was associated with increases 
in circulating complement C3 and C4, one week after surgery (Table 1). But this change was more 
gradual than immunoglobulin changes (Fig 2) and acute phase reactants [10], and C4 release was 
slightly reduced in VATS patients (Fig 2A). Increased C3 and C4 following surgery could indicate a 
VORZRQVHW³DFXWH-SKDVH´UHVSRQVH&DQG&PD\DOVRUHSUHVHQWDUHQDOUHVSRQVHWR,/-6 released as a 
result of trauma, particularly muscle damage [23, 24] which is lower in minimally invasive procedures.  
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Also, in a small preliminary study of circulating inflammatory and endothelial biomarker in part of the 
study group, increases in TNF receptor were observed (Table 2), which were smaller and slower than 
the rise in IL-6 levels (which peaked in these patients 4-12h after surgery). The kinetics of TNFR-II 
increases (Fig 3B) resembled C4 changes (Fig 3A) and these may be part of homeostatic responses to 
inflammatory stimuli elicited by surgery. Elevated circulating TNFR-II also correlates with progression 
of systemic inflammatory responses to sepsis and mortality [25].  A cellular target associated with 
metastatic progression is P-selectin [19], and the gradual TNFR-II increase we observed indicated 
greater endothelial cell adhesion following open surgery, with potential activation of P-selectin 
associated metastatic signals. There is an increasing interest in incorporating these novel metabolomic 
biomarkers into clinical trials in cardiovascular medicine. In summary, in this study, we analysed 
changes in immune opsonins and inflammatory/endothelial biomarkers in individual patients following 
surgery. Decreases in immunoglobulins indicated a period of immune suppression, and complement 
and endothelial biomarkers suggested an acute phase/inflammatory response following pulmonary 
surgery. These changes were observed in both open surgery and minimally invasive surgery patients. In 
immunoglobulin turnover and blood loss, advantages of the minimally invasive route were detected in 
the immediate post operative period. Our preliminary findings of changes in the inflammatory marker 
TNFR-II and in the delayed acute response associated with C4 release followed earlier and greater 
increases in acute phase reactants CRP and IL-6. However, when minimally invasive and open surgery 
were compared, these complement and TNFR-II changes showed much less difference than acute 
phase changes in the same cohort. High correlations between humoral and cellular immune responses 
and haemodynamic markers were detected following surgery, and there was a shift towards more 
positive correlations in certain immune parameters following minimally invasive surgery, suggesting a 
closer immune connectivity in patients undergoing minimally invasive surgery. 
 
The immediate postoperative period represents an opportunity for the use of therapeutic agents 
modulating immunological, acute phase and vascular signals which influence short term and long term 
survival. However, surgery is associated with substantial changes in these networks. This study 
supports the hypothesis that a decreased release of local trauma mediators, acute phase reactants, 
cellular immune and vascular responses all contribute to improved outcome and survival in minimally 
invasive surgery. Imaging techniques to detect local stress mediators will help define trauma signalling 
pathways at the site of surgery.  
 
ACKNOWLEDGEMENTS  
This study was undertaken as part of a postgraduate surgery study (SRC, supervised by WW). WW and 
SRC designed the clinical trial, performed the surgery and provided samples. HAL was involved in 
scientific design and assay performance and HAL and DR performed the data analysis and wrote up the 
study. Dr PL Yap provided immunoglobulin and complement determinations. We are grateful to Giuliana 
Rotondo for preparation of the dendrograph. Conflicts of interest: None declared. This work was supported 
by reagents grants from Chest Heart & Stroke Scotland and the Melville Trust for the Care and Cure of 
Cancer.
 13 
  
REFERENCES 
[1] Michils, A.;Lambert, J.P.;Yernault, J.C.;Fabry, V.;Gossart, B., Duchateau, J. Fine tuning of 
epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: 
towards a paraneoplastic immune marker. Cancer. 1996, 77, 657-664. 
[2] Ceppa, D.P.;Kosinski, A.S.;Berry, M.F.;Tong, B.C.;Harpole, D.H.;Mitchell, J.D.;D'Amico, T.A., 
Onaitis, M.W. Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary 
function: a Society of Thoracic Surgeons Database analysis. Ann. Surg. 2012, 256, 487-493. 
[3] Leaver, H.A.;Craig, S.R.;Yap, P.L., Walker, W.S. Lymphocyte responses following open and 
minimally invasive thoracic surgery. Eur. J. Clin. Invest. 2000, 30, 230-238. 
[4] Ng, C.S.;Wan, S.;Hui, C.W.;Wan, I.Y.;Lee, T.W.;Underwood, M.J., Yim, A.P. Video-assisted 
thoracic surgery lobectomy for lung cancer is associated with less immunochemokine 
disturbances than thoracotomy. Eur. J. Cardio-thoracic surgery. 2007, 31, 83-87. 
[5] Nosotti, M.;Rosso, L.;Mendogni, P.;Palleschi, A.;Tosi, D.;Bonara, P., Santambrogio, L. 
Leukocyte subsets dynamics following open pulmonary lobectomy for lung cancer: a prospective, 
observational study. Interact. Cardiovasc. Thorac. Surg. 2011, 13, 262-266. 
[6] Pu, Q.;Ma, L.;Mei, J.D.;Zhu, Y.K.;Che, G.W.;Lin, Y.D.;Wu, Z.;Wang, Y.;Kou, Y.L.;Yang, J.J., 
Liu, L.X. [Immune functions of patients following lobectomy for lung cancers: a comparative 
study between video-assisted thoracoscopic surgery and posterolateral thoracotomy]. Sichuan Da 
Xue Xue Bao Yi Xue Ban. 2013, 44, 126-129. 
[7] Friedrich, I.;Silber, R.;Baumann, B.;Fischer, C., Holzheimer, R. IgM-enriched immunoglobulin 
preparation for immunoprophylaxis in cardiac surgery. Eur. J. Med. Res. 2002, 7, 544. 
[8] Pilz, G.n.;Appel, R.;Kreuzer, E., Werdan, K. Comparison of early IgM-enriched immunoglobulin 
vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for 
sepsis. CHEST Journal. 1997, 111, 419-426. 
[9] Ytting, H.;Christensen, I.J.;Basse, L.;Lykke, J.;Thiel, S.;Jensenius, J.C., Nielsen, H.J.  Influence 
of major surgery on the mannan-binding lectin pathway of innate immunity. Clin. Exp. Immunol. 
2006, 144, 239-246. 
[10] Craig, S.R.;Leaver, H.A.;Yap, P.L.;Pugh, G.C., Walker, W.S. Acute phase responses following 
minimal access and conventional thoracic surgery. Eur. J. Cardiothoracic Surg. 2001, 20, 455-
463. 
[11] Hu, J.K.;Zhou, Z.G.;Chen, Z.X.;Wang, L.L.;Yu, Y.Y.;Liu, J.;Zhang, B.;Li, L.;Shu, Y., Chen, J.P. 
Comparative evaluation of immune response after laparoscopical and open total mesorectal 
excisions with anal sphincter preservation in patients with rectal cancer. World J. Gastroenterol. 
2003, 9, 2690-2694. 
[12] Katayama, M.;Handa, M.;Araki, Y.;Ambo, H.;Kawai, Y.;Watanabe, K., Ikeda, Y. Soluble P-
selectin is present in normal circulation and its plasma level is elevated in patients with 
thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Br. J. Haematol. 1993, 
84, 702-710. 
[13] Roselli, M.;Mineo, T.;Martini, F.;Mariotti, S.;Ambrogi, V.;Spila, A.;D'Alessandro, R.;Basili, 
S.;Guadagni, F., Ferroni, P.  Soluble selectin levels in patients with lung cancer. International J. 
Bio.l Markers. 2001, 17, 56-62. 
[14] Sakamaki, F.;Ishizaka, A.;Handa, M.;Fujishima, S.;Urano, T.;Sayama, K.;Nakamura, 
H.;Kanazawa, M.;Kawashiro, T.;Katayama, M. Soluble form of P-selectin in plasma is elevated 
in acute lung injury. Am. J. Respir. Crit. Care Med. 1995, 151, 1821-1826. 
[15] Glovsky, M.M.;Ward, P.A., Johnson, K.J. Complement determinations in human disease. Ann. 
Allergy Asthma Immunol. 2004, 93, 513-522; quiz 523-515, 605. 
[16] Ramadori, G.;Van Damme, J.;Rieder, H., Meyer zum Buschenfelde, K.H. Interleukin 6, the third 
mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. 
Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur. J. Immunol. 1988, 18, 
1259-1264. 
[17] Leen, C.L.;Yap, P.L., McClelland, D.B. Increase of serum immunoglobulin level into the normal 
range in primary hypogammaglobulinaemia by dosage individualization of intravenous 
immunoglobulin. Vox Sang. 1986, 51, 278-286. 
[18] Whicher, J.T.;Perry, D.E., Hobbs, J.R. An evaluation of the Hyland laser nephelometer PDQ 
system for the measurement of immunoglobulins. Ann Clin Biochem. 1978, 15, 77-85. 
 14 
[19] Garcia, J.;Callewaert, N., Borsig, L. P-selectin mediates metastatic progression through binding to 
sulfatides on tumor cells. Glycobiology. 2007, 17, 185-196. 
[20] Walker, W.S., Leaver, H.A. Immunologic and stress responses following video-assisted thoracic 
surgery and open pulmonary lobectomy in early stage lung cancer. Thorac. Surg. Clin. 2007, 17, 
241-249, ix. 
[21] Champault, G. [Has laparoscopic surgery reached its limits?]. J Chir (Paris). 1996, 133, 356-357. 
[22] Cook-Mills, J.M. VCAM-1 signals during lymphocyte migration: role of reactive oxygen species. 
Mol. Immunol. 2002, 39, 499-508. 
[23] Semple, S.J.;Smith, L.L.;McKune, A.J.;Hoyos, J.;Mokgethwa, B.;San Juan, A.F.;Lucia, A., 
Wadee, A.A. Serum concentrations of C reactive protein, alpha1 antitrypsin, and complement 
(C3, C4, C1 esterase inhibitor) before and during the Vuelta a Espana. Br. J. Sports Med. 2006, 
40, 124-127. 
[24] van de Vyver, M., Myburgh, K.H. Cytokine and satellite cell responses to muscle damage: 
interpretation and possible confounding factors in human studies. J. Muscle Res. Cell Motil. 2012, 
33, 177-185. 
[25] Punyadeera, C.;Schneider, E.M.;Schaffer, D.;Hsu, H.Y.;Joos, T.O.;Kriebel, F.;Weiss, M., 
Verhaegh, W.F. A biomarker panel to discriminate between systemic inflammatory response 
syndrome and sepsis and sepsis severity. J. Emerg. Trauma Shock. 2010, 3, 26-35. 
 
 
